ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 25 May to 31 May 2026

The 10 most important of the 133 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Neurology · J Headache Pain · 2026-05-25

Individual participant data meta-analysis of surveys in 38,512 adults aged 18-65 from 15 countries: 13.7% reported headache yesterday (females 17.1%, males 9.7%); adjusted global 1-day prevalence 13.1%, with migraine 5.7%, TTH 3.9% and pMOH 2.4%.

Meta-analysisn = 38,512
Husøy et al. Over 600 million people aged 18-65 will have headache tomorrow: global 1-day prevalence and recall bias from a meta-analysis of individual participant data (N = 38,512) from the general populations of 15 countries
Oncology · Eur J Cancer · 2026-05-25

Living systematic review of 41 RCTs (15,049 patients) in solid tumours: adding checkpoint inhibitors to radiotherapy did not significantly improve OS (HR 0.88, 95% CI 0.75–1.02; 28 trials), but did excluding glioblastoma (HR 0.83); PFS HR 0.80, EFS HR 0.73.

Meta-analysisn = 15,049
Tomassen et al. The survival impact of combining radiotherapy and immune checkpoint inhibitors in patients with solid tumors: A systematic review and living meta-analysis of randomized controlled trials

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.